Pinkie Fitts
Psychiatric/Mental Health · Aurora, CONPI 1407256217
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $353,887 of the $443,972 with a category attached, or 79.7%. Neurocrine Biosciences, Inc. accounts for 99.3% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $147,456, 3.5 times the $41,843 reported in 2021. Among psychiatric/mental health clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 675 payments — averaging $657.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$441K
- AbbVie$548
- Supernus Pharmaceuticals, Inc.$477
- Alkermes, Inc.$401
- Bausch Health US, LLC$319
- Otsuka America Pharmaceutical, Inc.$304
- plus $1K from 10 others
What the payments were for
- Consulting fees$20,2515%
- Speaking & faculty fees$353,88780%
- Travel & lodging$58,45413%
- Food & beverage$11,3343%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 464 | $440,667 |
| AbbVie | 39 | $548 |
| Supernus Pharmaceuticals, Inc. | 41 | $477 |
| Alkermes, Inc. | 20 | $401 |
| Bausch Health US, LLC | 22 | $319 |
| Otsuka America Pharmaceutical, Inc. | 21 | $304 |
| Lundbeck LLC | 12 | $233 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $199 |
| Sunovion Pharmaceuticals Inc. | 9 | $176 |
| Vanda Pharmaceuticals Inc. | 8 | $167 |
| Johnson & Johnson | 9 | $145 |
| Eisai Inc. | 11 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Teva Pharmaceuticals USA, Inc. | 4 | $55 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$434,867
How this compares
$443,972 in reported general payments places this provider in the 95th percentile of 873 psychiatric/mental health providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $102,727 |
| Clozapine | 22 | $2,764 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $1,398 |
| Aripiprazole | 45 | $949 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 11 | $921 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $644 |
| Bupropion XlBupropion Hcl | 20 | $607 |
| Trazodone Hcl | 53 | $545 |
| Quetiapine Fumarate | 34 | $523 |
| Duloxetine Hcl | 16 | $448 |
| Risperidone | 34 | $398 |
| Lamotrigine | 25 | $368 |
| Buspirone Hcl | 15 | $329 |
| Fluoxetine Hcl | 38 | $280 |
| Sertraline Hcl | 34 | $223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $440,667 | $102,72713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 873 psychiatric/mental health providers in Colorado.
Other psychiatric/mental health in Aurora
- Syreeta SpearsAurora$9K
- Marc WebbAurora$9K
- Karen LydaAurora$7K
- Chelsie MonroeLittleton$998K
- Audrey StrockDenver$499K
- Mark JankelowColorado Springs$287K
- Cristi BundukamaraColorado Springs$230K
- Deborah YorkDenver$158K
- Shelley AbadiLakewood$19K
- James AndersonWheat Ridge$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.